The Neurology Channel

The Anti-Depressant Citalopram Reduced Agitation in People with Probable Alzheimer’s Disease

The JAMA Report

2:15 | Neurology, Pharmacists, Preventative Health, The JAMA Report

Agitation is common in patients with Alzheimer’s disease. It is often expressed as aggression, excessive activity or hostility. A new study examined whether the anti-depressant drug citalopram is safe and effective for treating patients with Alzheimer’s disease. Catherine Dolf has more in this week’s JAMA Report.

More in Neurology

►

The Use of Virtual Reality for Pre-Procedural Planning and Practicing

Internal Medicine

Erik F. Wang, James Yu, DO, MS, John E. Rubin, MD, and Rohan Jotwani, MD, of the Department of Anesthesiology, Weill Cornell Medicine/New York-Presbyterian, New York, NY, describe the use...

► 1:29:36

How Can Metastatic Brain Tumors Affect Lung Cancer Care?

Neurology

Erin Dunbar, MD, director of Neuro-Oncology, Piedmont Atlanta Hospital, Atlanta, GA; Minesh Mehta, MD, chief of Radiotherapy, Baptist Health South Florida; Rohan Ramakrishna, MD, neurosurgeon, Weil Cornell Medical Center, New...

► 26:24

Novel Strategies for Treating Meningiomas

Neurology

Nancy Ann Oberheim Bush, MD, PhD, University of California San Francisco, discusses current and emerging devices and therapies for the management of meningiomas. Dr Oberheim Bush also noted that the...

► 22:47

Metastatic Brain Tumor Management

Neurology

Seema Nagpal, MD, Stanford University, Stanford, CA, discusses therapeutic options for the management of metastatic brain tumors. Dr Nagpal explains how the careful use of surgery, radiation, and targeted therapy...